Intra-Cellular Therapies, Inc.
ORGANIC COMPOUNDS
Last updated:
Abstract:
The present invention relates to PDEI inhibitory compounds of Formula I as described herein, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Status:
Application
Type:
Utility
Filling date:
2 Jan 2020
Issue date:
7 May 2020